NIH: Definition of Resilience and Pre-Symptomatic Disease in Lung Health and Disease (R01) – RFA-HL-15-024

To prospectively define and/or validate pulmonary or immune system attributes associated with pre-symptomatic disease states or resilience, with the goal of informing the development of primary prevention strategies for chronic lung diseases. $250,000 yr/3 years.

http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-024.html